Memantine vs Nivolumab
Memantine vs Nivolumab: Overview
This comparison examines the pharmacological differences between Memantine and Nivolumab.
Mechanism of Action
Memantine: Non-competitive NMDA receptor antagonist.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Memantine — 60-80 hours; Nivolumab — 27 days.
Chemical Properties
Molecular Formula: Memantine — C12H21N.
Molecular Weight: Memantine — 179.3080 g/mol.
Type: Memantine — Small molecule; Nivolumab — Antibody.